WASHINGTON, Dec. 3, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that it will deliver a corporate presentation at the 25 th Annual Piper Jaffray Healthcare Conference in New York City on Wednesday, December 4, 2013 at 11:30 a.m. Eastern Time.
The presentation at the Piper Jaffray Healthcare Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days. To access the presentation, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.Investor Contact: Chad RubinVice PresidentThe Trout Group(646) 378-2947 firstname.lastname@example.org SOURCE Vanda Pharmaceuticals Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts